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Abstract: Activated macrophages upregulate inducible nitric oxide synthase (iNOS) leading to the
profuse production of nitric oxide (NO) and, eventually, tissue damage. Using macrophage NO
production as a biochemical marker of inflammation, we tested different parts (flower, leaf, and
stem) of the medicinal plant, Spilanthes acmella. We found that extracts prepared from all three parts,
especially the flowers, suppressed NO production in RAW macrophages in response to interferon-γ
and lipopolysaccharide. Follow up experiments with selected bioactive molecules from the plant
(α-amyrin, β-caryophylline, scopoletin, vanillic acid, trans-ferulic acid, and spilanthol) indicated that
the N-alkamide, spilanthol, is responsible for the NO-suppressive effects and provides protection
from NO-dependent cell death. Spilanthol reduced the expression of iNOS mRNA and protein
and, as a possible underlying mechanism, inhibited the activation of several transcription factors
(NFκB, ATF4, FOXO1, IRF1, ETS, and AP1) and sensitized cells to downregulation of Smad (TF array
experiments). The iNOS inhibitory effect translated into an anti-inflammatory effect, as demonstrated
in a phorbol 12-myristate 13-acetate-induced dermatitis and, to a smaller extent, in cerulein-induced
pancreatitis. In summary, we demonstrate that spilanthol inhibits iNOS expression, NO production
and suppresses inflammatory TFs. These events likely contribute to the observed anti-inflammatory
actions of spilanthol in dermatitis and pancreatitis.
Keywords: dermatitis; pancreatitis; macrophage; nitric oxide; inducible nitric oxide synthase;
spilanthol; NFκB; FOXO1; IRF
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1. Introduction
Inflammation is the protective response of the innate immune system to an injury or pathogen
invasion. First, pathogen or damage-associated molecular pattern (PAMP or DAMP) molecules liberated
at the site of infection or tissue damage trigger pattern recognition receptors (PRRs). PRRs are expressed
at high levels in myeloid cells, such as patrolling monocytes, tissue-resident macrophages, dendritic cells,
and neutrophil granulocytes. Inflammatory macrophages release large amounts of proinflammatory
cytokines, chemokines, and reactive oxygen and nitrogen species (ROS/RNS) locally, which kills and
phagocytoses pathogens, activates the vascular endothelium, recruits and activates leukocytes [1].
Activated inflammatory macrophages play a central role in the orchestration of the inflammatory
response. In addition to producing a wide variety of proinflammatory cytokines and chemokines,
they are also important sources of reactive oxygen and nitrogen species (ROS/RNS). Macrophages
are capable of a sustained, high-level release of nitric oxide (NO) because they upregulate inducible
nitric oxide synthase (iNOS). The multifaceted role of NO, in both inflammation and the regulation
of adaptive immune responses, is not fully understood [2]. The administration of NOS inhibitors
in rodent models of inflammatory diseases curtails the severity of inflammation [3–6]. In addition,
there is a correlation between the activity of the disease and iNOS expression in inflamed tissues or
circulating monocytes [7]. NO mediates host defense and toxicity against microbes by inactivating
enzymes via reactivity with thiol-groups and iron in iron-containing proteins [8]. NO can also combine
with superoxide to form peroxynitrite, a highly reactive oxidant that attacks lipids and proteins.
Peroxynitrite has microbicidal activity but can also inflict damage to the host tissue [9–11]. NO has a
variety of effects on leukocyte function, including enhancement of macrophage motility, promotion
of macrophage apoptosis in high concentrations, and modulation of cytokine synthesis. NO plays a
role in resolving inflammation, along with TGF-β and IL-10 [12,13]. Therefore, NO is both a pro- and
anti-inflammatory molecule and a measurable marker of active inflammatory processes. Inflammation
becomes a major clinical challenge when maladaptive regulation leads to hyper-inflammation and
sepsis, eventually leading to distant organ failure. Current clinical anti-inflammatory treatment is
delivered largely through three classes of drugs: non-steroidal anti-inflammatory drugs (NSAIDs),
corticosteroids and selective cyclooxygenase-2 inhibitors (COXIBs) [14]. Recent research findings also
identified novel targets such as various secreted mediators or their receptors, intracellular signaling
molecules, and transcription factors (NFκB/IκB, MAP kinases, and AP-1), enzymes (PLA2, iNOS) and
the release of ROS/RNS [15]. Despite most modern approaches, such as in silico methods, rational
design, and high-throughput screening, ethnopharmacology still constitutes a significant source of
new drug candidates. The surging popularity of herbal medicines and a multi-target treatment
approach to reduce doses and improve efficacy and safety, lend legitimacy to the search for naturally
occurring complementary anti-inflammatory agents (e.g., curcumins, ginger, resveratrol, various plant
polyphenols, cannabinoids, epigallocatechin, capsaicin, and berberin).
Spilanthes acmella (S. acmella), also known as Acmella oleracea, is a subtropical flowering herb from
the Asteraceae family. Acmella oleracea has been used as a spice due to its acrid taste, the peculiar tingling
palatal sensation, and the accentuating effect on the taste of other food ingredients [16]. The plant and
its organic extracts also have a millennia-old history as a traditional folk remedy in many parts of the
world [16]. From the Amazon basin to India, the flowers, leaves, and stem have been chewed to cure
toothache, stomatitis, gingivitis, and sore throat due to a mild analgesic effect. In addition, S. acmella
has been used as an antiseptic, antiviral, antiparasitic, and diuretic, and for wound healing [17].
A number of chemical compounds, including essential oils, phytosterols, lipophilic alkylamides, have
been isolated from extracts of S. acmella [16].
In this study, we tested the anti-inflammatory properties of S. acmella. The effects of organic
solvent plant extracts on RAW264.7 inflammatory macrophages were investigated. We find that the
extracts reduce NO production in macrophages. Having tested six chemically pure substances selected
from a compendium of reported bioactive molecules previously identified in S. acmella in the same
assays, we attribute most of the observed effects to spilanthol, while trans-ferulic acid, vanillic acid,
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and scopoletin may also contribute to the inhibition of inflammatory macrophages. Down-regulation
of iNOS decreases NO production, suggesting that spilanthol interfered with the gene expression
of major inflammatory mediators. Spilanthol also conferred cytoprotection against the cell death of
activated macrophages. Spilanthol was able to markedly relieve the symptoms and histological signs of
acute inflammation in the mouse model of irritant contact dermatitis and reduced leukocyte migration
in acute pancreatitis.
2. Results
To obtain inflammatory macrophages, RAW264.7 cells were activated with lipopolysaccharide
(LPS) and interferon-γ (IFNγ). In line with previous studies [18], the combination of LPS and IFNγ
induced a massive production of nitric oxide, as indicated by increased nitrite content in the culture
medium (Figure 1B). In addition, LPS + IFNγ treatment caused a 55% reduction in macrophage viability
(Figure 1A). Pretreatment of cells with methanol extracts prepared from the flower (FEM), leaf (LEM),
or stem (SEM) of S. acmella caused a concentration-dependent suppression of NO production without
affecting cell viability (Figure 1C,D). These data confirmed that the extracts were non-toxic, and the
decreased NO release was not due to altered cell viability.
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Figure 1. S. acmella extracts are non-toxic and suppress NO production in LPS + IFNγ-treated RAW264.7
macrophages. RAW cells were stimulated with the indicated concentrations of LPS with or without
10 ng/mL IFNγ. (A) Cell viability was measured with MTT assay and (B) NO release was assessed
as NO2− levels in the cell culture medium. (C) RAW264.7 cells were treated with (up to 100 µg
extracted substance per ml of culture medium) the methanol extracts of floral (FEM), leaf (LEM) or stem
(SEM) tissue from S. acmella and viability was measured with MTT assay. The extracts did not affect
cell viability. (D) FEM, LEM, and SEM significantly and concentration-dependently decreased NO
production. The solid horizo tal line marks NO release fro 10 ng/mL LPS + 10 g/mL IFNγ-treated
cells in the presence of no plant extract. # Hashmarks indicate significant (### p < 0.001) changes
induced by IFNγ+ LPS in viability (A) r NO production (B) as well as sig ificant (# p < 0.05, ## p < 0.01,
### p < 0.001) inhibition of IFNγ + LPS-induced NO production by the plant extracts (D).
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In activated immune cells, upregulation of iNOS is responsible for most of NO production.
We, therefore, checked if S. acmella extracts affected iNOS expression in the LPS + IFNγ treated
RAW264.7 macrophages. LPS + IFNγ treatment was accompanied by a significant increase in iNOS
mRNA levels within 24 h compared to the non-treated cells. Pretreatment with S. acmella LEM, SEM,
or FEM extracts prevented the increased iNOS expression (Figure 2A). In accordance with these
findings, western blotting showed increased iNOS protein in response to LPS + IFNγ activation, which
was almost completely abrogated by LEM or FEM (Figure 2B,C). Data obtained from Western blot
experiments were confirmed by immunofluorescent staining of immunostimulated RAW macrophages
(Figure 2D,E).
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Figure 2. Flo er (FE ), leaf (LEM), or stem (SEM) extracts of S. acmella mitigate expression of
iNOS mRNA and protein in LPS + IFNγ-treated RAW264.7 macrophages. (A) RAW264.7 cells (CTR)
upregulated relative gene expression of iNOS upon activation with 10 ng/mL LPS + 10 ng/mL IFNγ
for 24 h in absence of plant extract (0). When the cells were cultured in the presence of FEM, LEM, or
SEM, iNOS mRNA expression was reduced by 30–50%. (B) iNOS protein expression was also induced
upon activation with 10 ng/mL LPS + 10 ng/mL IFNγ for 24 h in the absence of plant extract (lane 2 vs
lane 1). FEM, SEM and LEM almost completely abrogated iNOS upregulation when the cells were
cultured in the presence of plant extract. (C) Relative densities of the iNOS bands were determined.
(D) Microscope images showing immunofluorescent staining of RAW264.7 macrophages for iNOS (red)
with nuclear counterstain (blue). 10 ng/mL LPS + 10 ng/mL IFNγ treatment for 24 h in the absence of
plant extract enhanced iNOS staining. FEM, SEM, and LEM extracts reduced the iNOS signal to 40–45%
compared to LPS + IFNγ activated macrophages. (E) Intensities of the immunofluorescent iNOS signals
were quantified in ImageJ software. (* Stars indicate significant (*** p < 0.001) induction of iNOS mRNA
(A) or protein (C, E) production by IFNγ + LPS. #Hashmarks indicate significant (# p < 0.05, ## p < 0.01,
### p < 0.001) reduction of IFNγ + LPS-induced NO production by the plant extracts.).
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A number of compounds have been isolated from the organic extracts of S. acmella and chemically
characterized [16]. To identify the bioactive metabolite that provokes the iNOS inhibitory effects,
we treated LPS + IFNγ activated RAW264.7 cells with six chemically pure bioactive substances present
in S. acmella: spilanthol, β-caryophyllene, α-amyrin, trans-ferulic acid, vanillic acid, and scopoletin [19].
Treatment with trans-ferulic acid, vanillic acid, and scopoletin slightly decreased NO production
(by up to 30%) (Figure 3) accompanied by a similarly mild reduction of cell viability (Figure S1).
β-caryophyllene and α-amyrin decreased cell viability at and above 30 µM, thus the concomitant
decrease of NO release most probably correlated with decreasing cell numbers. In the non-toxic
concentration range, these substances did not affect NO levels. Lastly, spilanthol markedly suppressed
NO production in a concentration-dependent manner without causing any toxicity (Figure 3, Figure S1).
Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW 5 of 18 
 
A number of compounds have been isolated from the organic extracts of S. acmella and 
chemically characterized [16]. To identify the bioactive metabolite that pr vokes the iNOS inhibitor  
effects, we treated LPS + IFNγ activated RAW264.7 cel s with six chemically pure bioactive substances 
pres n  in S. acmella: spilanthol, β-caryophyllene, α-amyrin, trans-ferulic acid, vanillic acid, a d 
scopoletin [19]. Treatment with trans-f rulic acid, vanillic acid, nd scopoletin slightly decreased NO 
production (by up to 30%) (Figure 3) ac ompanie  by a similarly mild reduction of cell viability 
(Fig re S1). β-caryophyllene and α-amyrin decreased cel  viability at and above 30 µM, thus the 
concomitant decrease of NO release most probably correlate  with decreasing cell numbers. In the 
non-toxic concentration range, these substances did not affect NO lev s. Lastly, spilan ol markedly 
suppressed NO production in a conce tration-dependent manner without causing any toxicity 
(Figure 3, F gure S1).  
 
Figure 3. From a panel of selected chemical substances present in S. acmella extracts spilanthol is the 
most active in suppressing NO production. NO production of RAW264.7 cells activated with 10 
ng/mL LPS + 10 ng/mL IFNγ for 24 h. Cells were pretreated with increasing concentrations (0–100 
µM) of α-amyrin, β-caryophyllene, vanillic acid, trans-ferulic acid, scopoletin, and spilanthol. NO 
production was assessed from NO2- levels present in the cell culture medium. (* Stars indicate 
significant (*** p < 0.001) induction of NO production by IFNγ + LPS. #Hashmarks indicate significant 
(# p < 0.05, ## p < 0.01, ### p < 0.001) reduction of IFNγ + LPS-induced NO production by the test 
compounds.). 
Moreover, immunostimulated macrophages are known to develop cell dysfunction and display 
signs of cytotoxicity via iNOS-NO-ONOO--DNA breakage-PARP1 activation pathway [18]. Of the 6 
bioactive metabolites involved in our study, only spilanthol was able to prevent loss of viability in 
immunostimulated macrophages (Figure 4). The effect of spilanthol has also been confirmed using 
two additional assay methods, calcein and sulforhodamine assays (Figure S2). Therefore, next, we 
characterized the effect of spilanthol on iNOS expression. 
Figure 3. From a panel of selected chemical substances present in S. acmella extracts spilanthol is the
most active in suppressing NO production. NO production of RAW264.7 cells activated with 10 ng/mL
LPS + 10 ng/mL IFNγ for 24 h. Cells were pretreated with increasing concentrations (0–100 µM) of
α-amyrin, β-caryophyllene, vanillic acid, trans-ferulic acid, scopoletin, and spilanthol. NO production
was assessed from NO2− levels present in the cell culture medium. (* Stars indicate significant
(*** p < 0.001) induction of NO production by IFNγ + LPS. #Hashmarks indicate significant (# p < 0.05,
## p < 0.01, ### p < 0.001) reduction of IFNγ + LPS-induced NO production by the test compounds.).
Moreover, immunostimulated macrophages are known to develop cell dysfunction and display
signs of cytotoxicity via iNOS-NO-ONOO−-DNA breakage-PARP1 activation pathway [18]. Of the
6 bioactive metabolites involved in our study, only spilanthol was able to prevent loss of viability
in immunostimulated macrophages (Figure 4). The effect of spilanthol has also been confirmed
using two additional assay methods, calcein and sulforhodamine assays (Figure S2). Therefore, next,
we characterized the effect of spilanthol on iNOS expression.
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Figure 5. Spilanthol suppresses NO production in LPS/IFNγ-treated RAW264.7 macrophages by
mitigating expression of i S mRNA and protein. (A) Increasing concentrations of spilanthol
(0–100 µM) reduced iNOS mRNA expression in RAW264.7 macrophages activated with 10 nM LPS
+ 10 ng/mL IFNγ. (B) iNOS protein expression was als c ce trati - e e e tl inhibite by
spilanthol. (C) Relative d nsities of the iNOS bands were determin d. (D) Microscope images showing
immunofluorescent staining of the spilanthol treated cells for iNOS (red) confirmed the gradual loss
of iNOS staining with increasing concentr tions of the drug. Blue is DAPI nuclear counterstain.
(E) Inten ities of the immunofluorescent iNOS signals were quantified in Imag J softwar . (* p < 0.05,
*** p < 0.001, # p < 0.05, ## p < 0.01, ### p < 0.001).
Several transcription factors (e.g., NFκB, AP1, and IRF1) have been implicat d in the transcriptional
regulation of iNOS. Therefore, we investigated the tran cription factor (TF) activation pathways that
m y be targeted b spil nthol in immu ostimulated macroph ges. Using TF array, we found
that several TFs become activated after LPS + IFNγ stimulation, with NFκB displaying the highest
levels of activation (Figure 6). Treatment with 100 µM spilanthol nearly elimi ated the bi ding of
nuclear NFκB to its cognate re p nse element, which is due to interfer nce with upstream signaling,
reduced translocation from the cytoplasm to the nucleus, or interference with cons sus motif binding.
Other TFs affected by spilanthol (> 85% inhibition) included ATF4, FOXO1, and IRF (Figure 6). TFs
that were affected by spilanthol to a lesser degree (at least 60% inhibition) included AP1 and ETS. Smad
was the only TF th t was in ibited after LPS + IFNγ s imulation. Interestingly, spilanthol sen itized
cells to Smad downregulation.
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Figure 6. Spilanthol downregulates transcription factor pathways involved in inflammatory gene
regulation. We tested the binding of 15 transcription factors to their cognate response elements in
nuclear extracts of LPS + IFNγ and LPS + IFNγ + spilanthol treated cells by a transcription factor
binding assay. The experiment was performed in duplicate (#1 and #2). The heatmap depicts the change
of binding intensity of TFs compared to untreated cells. Binding comparable to that of the untreated
cells is rendered in black, increased binding is shown in shades of red, and decreased binding in green,
corresponding to the color bar. In the right panel, the level of residual TF binding after treatment
with spilanthol is color-coded, so as darker colors denote increasingly pronounced inhibitory effect by
spilanthol and white denotes no effect. We observed consistent downregulation in both experiments to
≤ 15% in the binding of NFκB, IRF, ATF4, and FOXO1.
In light of our finding that spilanthol inhibited NO production and perturbed inflammatory TF
activation in macrophages, we next investigated the in vivo effectiveness of spilanthol in an irritant
contact dermatitis model and in experimental acute pancreatitis. Skin irritation was provoked by
smearing PMA onto the ears of BALB/c mice, control mice were treated with vehicle (DMSO) only.
Erythema and swelling, indicating the development of inflammation, developed within 6 h after
application of the irritant. To follow the inflammatory response, we measured the thickness of ears with
a micrometer caliper. Hematoxylin-eosin stained histological sections of the ears revealed that PMA
induced massive inflammation (Figure 7A). Spilanthol treatment resulted in a marked reduction of
average ear thickness from 0.34 to 0.26 mm, indicating that spilanthol inhibited the edematous response
(Figure 7A,B). The number of infiltrating leukocytes was also reduced markedly after spilanthol
treatment (Figure 7C).
Secretagogue overstimulation-induced pancreatitis was elicited by intraperitoneal injection of
50 µg/kg cerulein. Ensuing acinar cell death was indicated by elevated serum α-amylase levels
(Figure 7D). Myeloperoxidase (MPO) activity, an indicator of neutrophil infiltration, increased
substantially in the pancreatic tissue after cerulein treatment (Figure 7E). Intraperitoneal administration
of 30 mg/kg spilanthol was ineffective in reducing pancreatic cell damage but inhibited neutrophil
infiltration as indicated by the reduction of MPO activity in the excised tissue (Figure 7E).
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3. Discussion
Billions of people in the world live outside the reac f r icine without quality health
care systems. These people, particularly in rural, re ote, and less developed areas, rely on traditional
treatments when sick. The safety and benefit of this enormous number of consumers necessitate
the rigorous, evidence-based scientific investigation into the pharmacological potency, efficacy, and
pharmacodynamics of these traditional remedies. Folk remedies and herbal medicines are enjoying
a revival and attract more interest from members of developed societies, thanks to their appeal to
naturalist groups and the recognition by western medicine of the worth of traditional cures and
procedures, as complementary medical practices [20,21]. The UN’s public health agency, the World
Health Organization, embraced the potential of traditional medicine and the promotion of the safe and
effective use of traditional medicine by researching and integrating its products into health systems in
its Traditional Medicine Strategy 2014–2023.
S. acmella is a plant cultivated for its ornamental beauty, its use in cooking, and for the anecdotal
curative powers in Indonesia, India, Bangladesh, Central-Africa, and northern Brazil. Various parts
of the plant have long been known to alleviate painful maladies of the oral cavity and data in the
literature also hint at its potential anti-inflammatory potential [17]. In the current study, we chose
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LPS-stimulated macrophages representing a central player in the inflammatory process and focused
on NO production as a hallmark for inflammatory macrophage activation. Our findings showing that
extracts prepared from various parts of the plant suppressed NO production in activated macrophages
suggest the underlying mechanism for the potential anti-inflammatory effects of this plant. Different
parts of the S. acmella plant had slightly different NO inhibitory effects, with flowers being the most
potent and stems being the least potent. However, all three plant parts inhibited NO production
significantly. As expected, S. acmella extracts suppressed iNOS expression both at the mRNA and
protein levels, providing an explanation for the reduced NO production elicited by pretreatment with
the extracts in LPS-induced macrophages.
S. acmella is a rich source of bioactive compounds, so we set out to identify the most likely candidate
mediating inhibition of NO production. Several studies have been carried out to analyze the chemical
composition of S. acmella extracts eventually yielding a large variety of compounds [17]. The most
abundant class is N-alkylamides. Spilanthol, (2E, 6Z, 8E)-N_isobutylamide-2,6,8-decatrienamide,
is the major representative of the alkylamides. Other bioactive components worth mentioning include
triterpenoidal saponins [22], mono-, sesqui-, and triterpenoids (e.g., α-amyrin), phytosterols, coumarin
derivatives (e.g., scopoletin), and lignocelluloid components (e.g., trans-ferulic acid and its derivative
vanillic acid) [16,17].
Of the tested bioactive compounds of S. acmella, spilanthol clearly emerged as the most effective
ingredient inhibiting NO production. Spilanthol was the only test compound that also prevented
activated macrophage cell death caused by NO-derived peroxynitrite production, DNA breakage, and
PARP1 activation. Spilanthol suppressed the levels of iNOS mRNA and protein suggesting that its
effects are transcriptional. These data suggest that spilanthol may be responsible for the iNOS/NO
suppressing effects of our plant extracts. Indeed, HPLC-UV analysis revealed a very high spilanthol
content in the extracts with flower, leaf, and stem extracts containing 26.81 ± 0.04, 7.42 ± 0.04 and
3.59 ± 0.01% (wt/wt) spilanthol, respectively.
The exact mechanism by which spilanthol regulates iNOS and NO production is not yet known.
Downstream signaling from LPS sensing TLR4 receptors engages the NFκB pathway, while IFN
receptors mediate signals through the Jak/STAT1 pathway. Several interacting signaling pathways
regulate iNOS expression and are dependent on the cell type and stimulus.
Our TF array experiments highlight the central role of NFκB inhibition in spilanthol-treated cells.
The NFκB pathway plays a pivotal role in the development of the inflammatory phenotype of various
immune cells. As expected, LPS + IFNγ caused a marked (7–8 fold) increase in NFκB activation that
was fully abolished by spilanthol. NFκB is thought to be predominantly responsible for elevated
expression of iNOS and production of NO. The many direct and downstream target genes of NFκB
include COX-2, TNFα, IL-6, and proIL1-β. Therefore, the NFκB suppressing effect of spilanthol likely
decreases many inflammatory mediators in addition to iNOS.
AP-1 and interferon regulatory factor (IRF)-1 are also known to co-regulate the iNOS promoter [23].
These two TFs are also suppressed by spilanthol and may contribute to the effect on NO production.
The transcription factor, Smad, was downregulated by LPS + IFNγ treatment and spilanthol sensitized
cells to Smad suppression. Smad is the central transcription factor mediating the effects of TGFβ,
a potent anti-inflammatory cytokine, which suppresses the expression of iNOS [24]. TGFβ–induced
signals lead to reduced iNOS expression [25] via both transcriptional effects and destabilization of
iNOS mRNA and protein [26]. There is a well-known antagonism between TGFβ and NFκB [27].
The RelA subunit of NFκB is responsible for the inhibition of TGFβ-induced phosphorylation,
nuclear translocation, and DNA binding of SMAD signaling complexes induced by LPS, TNFα
or IL1β. The mechanism of antagonism between these two signaling pathways relies on RelA-induced
expression of inhibitory Smad7 protein [27], which antagonizes TGFβ signaling at various levels
(for details see [28]). Whether spilanthol exerts NO inhibitory effects primarily via potentiation of Smad
signaling or by inhibition of pro-inflammatory pathways is still in question. However, considering the
mutual antagonism between these pathways, both options are theoretically possible.
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We chose a systemic and local inflammatory disorder in order to understand the effects of
spilanthol on granulocyte migration. Pancreatitis seems to be one of the most suitable systemic
inflammatory diseases for several reasons: (i) the incidence rate of pancreatitis continuously elevates
causing an increasing healthcare need for specific treatment [29], (ii) the mortality rate is usually high
due to the systemic inflammation [30], (iii) the mortality rate is unacceptably high (around 30%) in its
severe form [30], (iv) granulocytes are involved in the pathomechanism of the disease [31], and finally
but very importantly, (v) there is no specific treatment to cure acute pancreatitis [32]. The choice of
dermatitis as a local inflammatory disease is justified by the very high incidence of the various forms
of dermatitis (atopic, seborrheic, contact, irritative, radiation-induced, etc.), its effect on the quality of
life and easily available animal model with local treatment option [33].
The iNOS inhibitory effect of spilanthol translated into anti-inflammatory actions as observed in
the dermatitis model. The compound significantly reduced ear edema and granulocytic infiltration
of the tissue. Reprogramming inflammatory transcription factor activation pathways are likely to be
crucial as underlying mechanisms for this anti-inflammatory effect. As for the inhibition of granulocytic
infiltration, spilanthol inhibits adhesion molecule expression [34,35] and similar events may contribute
to reduced inflammatory cell migration in spilanthol treated mice. Interestingly, spilanthol failed
to protect mice from secretagogue-induced acinar cell damage, although it significantly reduced
granulocyte infiltration. This suggests that granulocyte infiltration is a secondary event triggered by
acinar damage.
4. Materials and Methods
4.1. Plant Collection and Preparation of Its Extracts
Twenty grams (20 g) of dry powders of different parts of the plant (leaves, flowers, and stems)
were extracted with 200 mL of methanol using Soxhlet extractor and dried under reduced pressure
in a rotary evaporator (R-100; BÜCHI India Pvt. Ltd., Mumbai, Maharashtra, India). The resultant
amorphous solid forms of the plant extracts were stored at 4 ◦C.
The Spilanthes acmella plant was collected during the pre-monsoon period (March-May) from
Doiwala, India (Latitude: 30◦09′23.1”N; Longitude: 078◦07′01.0”E) and was authenticated by the
Botanical Survey of India (BSI), Dehradun (Acc. No. 118066). Different parts of the plant, including
leaves, flowers, and stem (arial) parts without leaf and flower were separated, washed under tap water,
and dried at 50 ◦C in a hot air oven. The dried samples were ground into fine homogenized powders
using a sharp blender and stored in airtight bottles. Twenty grams (20 g) of dry powders were then
extracted in 200 µL methanol using a Soxhlet extractor and dried under reduced pressure in a rotary
evaporator (R-100; BÜCHI India Pvt. Ltd., Mumbai, Maharashtra, India). The resultant amorphous
solid forms of the plant extracts were stored at 4 ◦C.
4.2. HPLC-UV Method
HPLC-UV measurements were performed with a Waters 2695 Separations Module equipped with
a thermostable autosampler (5 ◦C) and a column module (35 ◦C), a Waters 2996 Photodiode-array
detector with a Waters Symmetry C18 column 3.9 × 150 mm, 5 µm) (each from Waters, Milford, MA,
USA). Gradient elution at a flow rate of 1 mL/min was applied. Injection volume was 50 µL. The mobile
phase A was water with 0.1% trifluoroacetic acid and B was acetonitrile with 0.1% trifluoroacetic acid.
The gradient condition was as follows: initially 65% A and 35% B, 0–22 min linear change to 54% A
and 46% B, 22–24 min linear change to 20% A and 80% B, and held to 34 min, 34–35 min linear change
to 65% A and 35% B, and held to 45 min. The analytes were detected at the range of 210–400 nm,
for qualitative analysis 230 nm was selected. The method was proved to be linear for spilanthol in the
range of 3–50 µg/mL.
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4.3. Cell Culture
RAW264.7 macrophages were cultured in a 5% CO2 incubator at 37 ◦C using an endotoxin-free
modified Dulbecco’s minimal essential medium (Sigma–Aldrich, Budapest, Hungary) supplemented
with 10% fetal bovine serum, 4 mM L-glutamine, and 10 µL per ml antibiotic, antimycotic solution
(Sigma–Aldrich, Budapest, Hungary)
4.4. Cell Treatments
Cells were seeded in 96 well tissue culture plates (104/well) for cytotoxicity and total nitrite
determination assays, 12 well tissue culture plates (105/well) for real-time PCR measurements, 6 well
tissue culture plates (106/well) for Western blot analysis, and onto glass coverslips placed into 24
well tissue culture plates (2 × 104/well) for immunofluorescence. The next day, cells were pretreated
with either plant extracts or test compounds, including vanillic acid, α-amyrin, β-caryophyllene,
trans-ferulic acid, scopoletin (Sigma-Aldrich, Budapest, Hungary), and spilanthol (Santa Cruz) at
the indicated concentrations for 2 h followed by treatment with LPS (10 ng/mL) (Sigma–Aldrich,
Budapest, Hungary) and IFNγ (10 ng/mL) (Bio-Vision) for 24 h. Test compounds were first dissolved
in DMSO (stock solution) and were then further diluted in culture medium for cell-based experiments.
DMSO concentrations were at or below 1% (v/v) in cell cultures which did not have any effect on the
parameters measured.
4.5. Viability Assay
Cell viability was assessed using the colorimetric MTT assay [36]. After treatments, MTT
(Sigma-Aldrich, Budapest, Hungary) was added to the cells (0.5 mg per mL) and incubated for an
additional hour. The medium was then aspirated and the formazan crystals were dissolved by the
addition of 100 µL dimethylsulfoxide. Optical density was determined at 540 nm in a plate reader
(Tecan Spark, Tecan, Switzerland). Viability was calculated and expressed as a percent of control.
4.6. Sulphorhodamine B (SRB) Assay
Cells were fixed by the addition of 25µL 50% TCA to cells in 100 µL medium and incubated at
4 ◦C for 1 h. After washing three times with distilled water and air drying, 100 µL SRB solution (0.4%
SRB/1% acetic acid) was added to the wells and plates were incubated for 10 min. After removal of
the SRB solution, cells were washed five times with 1% acetic acid and air dried. Bound SRB was
dissolved by adding 100 µL of 10 mM unbuffered Tris Base (pH 10.5) to each well and shaking for
30 min. Optical density was determined at 515 nm in a plate reader (Tecan Spark, Tecan, Switzerland).
Viability was calculated and expressed as a percent of control.
4.7. CalceinAM Assay
Culture medium was aspirated and replaced by 50µL CalceinAM solution (1µM CalceinAM/medium).
After 40 min incubation at 37 ◦C, fluorescent intensity was determined at 485/535 nm in a plate reader
(Tecan Spark, Tecan, Switzerland). Viability was calculated and expressed as a percent of control.
4.8. Measurement of Total Nitrite Content
Nitrite content was measured using the Griess method as described [37]. Fifty µL of cell culture
supernatants and sodium nitrite standards were transferred into a new 96 well plate. Another 50 µL
of Griess reagent [50% of 1% sulfanilamide (Sigma–Aldrich, Budapest, Hungary) and 50% of 0.1%
naphthylethylene-diamine dihydrochloride (Sigma–Aldrich, Budapest, Hungary) (dissolved in 5%
H3PO4)] was added into each well and incubated at room temperature for 20 min. Absorbance was
measured in a plate reader (Tecan Spark, Tecan, Switzerland) at 540 nm.
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4.9. RNA Extraction, Reverse Transcription, and Real-Time PCR Analysis
Total RNA was isolated from cells with TRI reagent (Molecular Research Center) and RNA purity
was checked measuring A260/280 ratio. Reverse transcription and Quantitative real-time PCR was
performed as described previously [38]. Gene expression levels were normalized to the geometric
average of glyceraldehyde-3-phosphate dehydrogenase, β-actin, β-2-microglobulin, and hypoxanthine
phosphoribosyltransferase-1 as reference housekeeping genes.
4.10. Immunofluorescent Detection of iNOS
Detection of iNOS was carried out by immunofluorescent staining following standard protocols [39]
with modifications as follows. After treatment, cells were fixed in St. Mary solution (1% v/v acetic
acid in ethanol) for 1 h at 4 ◦C, and then rehydrated in PBS for 5 min at room temperature. Coverslips
were blocked with 1% BSA–20% FCS-Fc receptor blocker (kind gift from Dr. Zsolt Bacsó, Debrecen,
Hungary) 1:400 diluted in phosphate-buffered saline (PBS)–Triton X-100 for 1 h at RT and then incubated
overnight at 4 ◦C with monoclonal rabbit anti-iNOS antibody (Sigma–Aldrich, Budapest, Hungary)
diluted 1:5000 in blocking solution. After 5 × 5 min washes in PBS, coverslips were incubated with
AlexaFluor546-conjugated anti-rabbit IgG antibody (Life Technologies, Budapest, Hungary) diluted
1:500 for 1 h at room temperature. Nuclei were stained with 2µg/mL DAPI in PBS for 1 h at RT.
Coverslips were mounted with Mowiol/ DABCO and samples were imaged with a Leica SP8 confocal
microscope and evaluated with ImageJ software.
4.11. Western Blot Analysis
Western blots were carried out as previously described [40,41]. Briefly, cells were washed once in
PBS and collected by scraping into 100 µL of ice-cold lysis buffer (62.5 mM Tris-HCl, pH 6.8, 2% SDS,
10% glycerol, 1 mM PMSF, and protease inhibitors). The extracts were further lysed with sonication
and the supernatants were collected after centrifugation. Protein concentrations were determined with
the Pierce BCA reagent (Thermo Fisher, Budapest, Hungary). Proteins (30 µg/lane) were separated
in 10% SDS-PAGE and transferred to nitrocellulose membranes. Membranes were blocked with
5% non-fat dry milk in Tris-buffered saline (TBS) for 90 min. Primary antibodies against iNOS
(rabbit monoclonal; Sigma-Aldrich, Budapest, Hungary) were applied overnight at 4 ◦C. After three
washes in TBS containing 0.05% Tween 20, the secondary antibody (peroxidase-conjugated goat
anti-rabbit IgG, Sigma-Aldrich, Budapest, Hungary) was applied for 1 h. Blots were washed in TBS
containing 0.05% Tween 20 three times and once in TBS. After washing, the blots were incubated in
Pierce Supersignal Chemiluminescent reagent (Thermo Fisher, Budapest, Hungary). For detection
of luminescence, Chemidoc Touch gel documentation system (BioRad) was used and signals were
quantified by densitometry using the ImageLab 6.0 software.
4.12. Transcription Factor Activation Profiling
Nuclear extract preparation and transcription factor activation profiling were carried out using
the nuclear extract preparation Kit (Signosis, Santa Clara, USA) and the Oxidative Stress TF Activation
Profiling Plate Array (Signosis, Santa Clara, USA) following the manufacturer’s instructions.
4.13. Contact Hypersensitivity (CHS)
Animal studies involving CHS experiments were approved by the institutional animal welfare
committee (protocol 15/2016/DEMÁB) and were carried out as previously described [42] with
modifications as follows. BALB/c mice were used, including 18 male and 18 female mice. All mice
were 10–12 weeks old, and bred and maintained under temperature- humidity- and light-controlled
conditions (21–23 ◦C, 30–60% relative humidity, 12 h light/dark cycle). All mice were fed ad-libitum
VRF1 (P) food and water, and they were housed in Eurostandard Type II cages.
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CHS was induced with phorbol 12-myristate 13-acetate (PMA). Animals were divided into three
groups. The control group was treated with dimethylsulfoxide (DMSO), the vehicle of PMA. The PMA
group was treated with 0.05% PMA and the PMA-spilanthol group with 0.05% PMA and 10 µM
spilanthol (in DMSO). Before the induction of inflammation, ear-thickness of mice was measured with
a Mitutoyo thickness gauge. Mice were then treated with DMSO or PMA (20 µL/ear applied with
a micropipette, 10 µL to each side of the ear). Sixty minutes later the control and the PMA groups
were treated with DMSO and the PMA-spilanthol group was treated with 10 µM spilanthol (20 µL
smeared onto ears with micropipette, 10 µL to each side of the ear). The selection of the spilanthol
concentration was based on experiments showing the effects of spilanthol on NO production (Figure 3).
Six hours after the PMA treatment, the ear-thickness was measured again and mice were euthanized
with isoflurane. The ears of the animals were removed for histology (hematoxylin-eosin staining) and
MPO assays.
4.14. Cerulein-induced Acute Pancreatitis (AP)
Animal studies involving AP experiments were approved by the institutional animal welfare
committee (protocol 25/2017/DEMÁB) and were conducted as previously described [43] with
modifications as follows. Ten- to twelve-week-old male C57BL/6 mice were used for cerulein-induced
AP. The animals were kept under standard conditions with a 12-h light/dark cycle. All mice were
fed with a standard diet and received water ad libitum during the experiments. Mice (n = 42) were
divided into three groups. In the cerulein-treated group, AP was induced by eight intraperitoneal
injections of cerulein (50 µg/kg) at hourly intervals. In the cerulein + spilanthol group, mice received
one intraperitoneal injection of spilanthol (30 mg/kg) 1 h before the first cerulein injection. (The DMSO
content of the ca. 200 µL spilanthol solutions was 3.3%.) Mice in the control and cerulein groups were
given saline (with 3.3% DMSO) only. Blood and pancreas were collected when mice were sacrificed
24 h after the first injection. The selection of the spilanthol dose was based on literature data showing
that spilanthol has antinociceptive effect at this dose [44] and we hypothesized that anti-inflammatory
effect may be observed in the same dose.
4.15. Serum Amylase Determination
Blood samples were taken by cardiac puncture and centrifuged at 5000 rpm for 15 min at 4 ◦C.
Serum amylase activity was measured (using an enzymatic assay kit from Diagnosticum Zrt., Budapest,
Hungary) in a kinetic reaction over 30 min using a Spark photometric plate reader (Tecan, Männedorf,
Switzerland) at 405 nm.
4.16. Myeloperoxidase (MPO) Activity
Tissue MPO activity was measured as an indicator of neutrophil infiltration in the ear and
pancreas as described [45] with modifications as follows. Tissue samples were weighed, thawed, and
homogenized in 1 mL of 20 mmol/L phosphate buffer (pH 7.4), and then centrifuged at 13,000 rpm for
30 min at 4 ◦C. The resulting pellet was resuspended in 0.5 mL of 50 mmol/L phosphate buffer (pH 6.0)
containing 0.5% HTAB (Sigma). The homogenates were then frozen in liquid nitrogen and thawed
on three consecutive occasions before sonication. The samples were then centrifuged (13,000 rpm
for 30 min at 4 ◦C), and the supernatants were collected for the MPO assay. Supernatant (100 µL)
was mixed with 100 µL solution of 1.6 mM 3,3′,5,5′-tetramethylbenzidine (Sigma Aldrich, Budapest,
Hungary) and 1 mM hydrogen peroxide. The mixture was incubated at 37 ◦C for 120 s, and the reaction
was stopped with 200 µL 2 M H2SO4. The absorbance was measured at 450 nm and then normalized
to tissue weight.
4.17. Statistical Analysis
All values are expressed as mean ± SEM and experiments were repeated at least three to four
times. First, we ran Kolmogorov-Smirnov test to check if data have normal distribution. If they did
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we performed one-way ANOVA followed by Dunnett’s post hoc test. Data that didn’t show normal
distribution were analyzed with Kruskal-Wallis tests followed by Dunn’s post hoc test. The value of
p < 0.05 was considered significant.
5. Conclusions
Overall our study identified spilanthol as a potent bioactive molecule that reduces NO production
in activated macrophages. Spilanthol interferes with activation of several TFs known to switch on
the iNOS promoter. The iNOS suppressing effect of spilanthol translates into anti-inflammatory
action (reduction of inflammatory cell migration) both in dermatitis and in pancreatitis. As a
consequence, edema is reduced in dermatitis but acinar damage remained unaffected by spilanthol.
Since extravasation of granulocytes and monocytes is a central and early event in most forms of
inflammation, the beneficial effects of spilanthol may likely to be extended to a broad range of
inflammatory conditions.
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Figure S2. Confirmation of the cytoprotective effect of spilanthol in RAW macrophages.
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Abbreviations
iNOS inducible nitric oxide synthase
FEM flower extract in methanol
LEM leaf extract in methanol
SEM stem extract in methanol
NFκB nuclear factor kappa B
ATF4 activating transcription factor 4
FOXO1 forkhead box protein O1
IRF1 Interferon regulatory factor 1
ETS E26 transformation-specific (transcription factor)
AP1 Activator protein 1
PMA phorbol 12-myristate 13-acetate
PRR pattern recognition receptors
ROS reactive oxygen species
NO nitric oxide
RNS reactive nitrogen species
DAMP damage associated molecular pattern
PAMP pathogen-associated molecular pattern
TGFβ transforming growth factor beta
IFNγ interferon gamma
DABCO 1,4-diazabicyclo[2.2.2]octane
DAPI 4′,6-diamidino-2-phenylindole
PBS phosphate buffered saline
TBS Tris-buffered saline
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LPS lipopolysaccharide
NSAIDs Non-steroidal anti-inflammatory drugs
COX-2 cyclooxygenase-2
COXIBs cyclooxygenase-2 inhibitors
PLA2 phospholipase A2
CHS contact hypersensitivity
DMSO dimethylsulfoxide
HTAB hexadecyltrimethylammonium bromide
MPO myeloperoxidase
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